FDA approves 5 rapid COVID-19 test kits

The Food and Drug Administration (FDA) has approved five rapid test kits for COVID-19, allowing for faster detection of the virus.

These point-of-care test kits are registered for use in countries with reliable regulatory agencies, including China and Singapore.

Additionally, the FDA approved the SARS Cov2 kit from Abbott Laboratories, a PCR-based test that can detect the virus in just five minutes.

FDA Director General Eric Domingo advised caution in using the rapid test kits, emphasizing that they measure antibodies and not the viral load.

Domingo stressed the importance of trained health professionals evaluating and interpreting the results of these rapid tests.

A confirmatory PCR-based test is still necessary even after a rapid test yields a result.

Topics in this story

Explore more stories about these topics.

🤖

This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.

News Sources

See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.